Moderate Alcohol Intake Associated with Less Chronic Pain, Depression

People with chronic pain or fibromyalgia who engage in low-risk drinking habits report fewer symptoms and improved function than teetotalers.

7:00 AM

Author | Kelly Malcom

Many people jokingly refer to their occasional glass of wine after work as medicine. A new study hints at there being some truth to the perceived pain-relieving effects of moderate alcohol consumption. 

U-M pain researchers investigated this connection in people seeking treatment for chronic pain or fibromyalgia, a condition that causes widespread pain throughout the body, and can affect mood, cognition and sleep.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunes, Google Play and Stitcher.

For the study, published in the journal Pain Medicine, lead author Ryan Scott, MPH, of the Michigan Medicine Chronic Pain and Fatigue Research Center and his team surveyed 2,583 people with chronic pain and fibromyalgia about their drinking habits, pain severity and physical function. The researchers also examined psychological measures, such as anxiety and depression.

[Low-risk alcohol intake] could be a stepping stone to increased quality of life, leading to more social interactions.
Ryan Scott, MPH

Moderate consumption

In the U.S., moderate alcohol consumption is defined as one drink per day for women and two drinks per day for men.

Research has shown several benefits to moderate alcohol consumption, including decreased risk of coronary heart disease, stroke and dementia and increased physical function and quality of life.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

Despite these benefits, this new study found that overall, people with chronic pain tend to drink less than the general population. "People with chronic pain may drink less due to the stigma and because they are being told not to drink while on pain medication," says Scott.

Of the study participants, more than half reported use of opioid medication, which carries serious risks when combined with alcohol.

Moderate drinkers with chronic pain were more likely to be male, white and hold an advanced degree and were less likely to use opioids. They reported less pain, lower anxiety and depression, and higher physical function. Women who were moderate drinkers reported the same state of being.

Interestingly, people with fibromyalgia symptoms who drank moderately reported decreased pain severity and depression but saw no effect on how widespread their pain was or other symptoms such as cramps, headache, fatigue, unrefreshing sleep and cognitive dysfunction.

Increasing GABA 

"Alcohol increases gamma-aminobutyric acid (GABA) in the brain, which is why we could be seeing some of the psychiatric effects. Even though alcohol helped some fibromyalgia patients, it didn't have the same level of effect," says Scott.

"You probably need much more GABA to block pain signals and that may be why we're not seeing as high an effect in these patients," he says.

SEE ALSO: Why Shame Keeps Patients from Alcohol Use Disorder Treatment

GABA is a neurotransmitter in the central nervous system responsible for reducing the activity of neurons. Drugs that act on GABA typically have relaxing effects.

Though these findings seem to point at low-risk alcohol intake as a promising analgesic, Scott doesn't anticipate doctors prescribing a drink anytime soon — mainly due to liability, the health risks associated with heavy drinking, and the fact that many first-line pain medications are contraindicated with alcohol.

The team calls for more substantial studies to determine appropriate intake of alcohol for pain relief, especially given the fact that chronic pain patients have a higher prevalence of alcohol abuse.

For now, Scott suggests patients talk to their health care provider about the pain-relieving effects and reduced depression that appear to come along with moderate drinking.

"It could be a stepping stone to increased quality of life, leading to more social interactions," he says. "Fibromyalgia patients in particular have a lot of psychological trauma, anxiety and catastrophizing, and allowing for the occasional drink might increase social habits and overall health."

 


More Articles About: Lab Report chronic pain Fibromyalgia Pain management
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories
Health Lab
Does an Exploding Brain Network Cause Chronic Pain?
New research reports that hyperreactive brain networks could play a part in the hypersensitivity of fibromyalgia.
Health Lab
Does Widespread Pain Stem from the Brain? MRI Study Investigates
A new neuroimaging study investigating the effect of widespread pain on the brain reveals patients with different chronic pain diagnoses show similar brain changes.
mushrooms in a microscope
Health Lab
How cannabis and psilocybin might help some of the 50 million Americans experiencing chronic pain
Recent developments represent a dramatic change from long standing federal policy around these substances that has historically criminalized their use and blocked or delayed research efforts into their therapeutic potential.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Addiction is a lifelong disease and not a moral failing
On today’s The Fundamentals is Dr. Brummett, Professor at the University of Michigan where he serves as the Senior Associate Chair for Research in the Department of Anesthesiology. He has more than 280 publications, including articles in top journals such as JAMA, JAMA Surgery, Anesthesiology, and Annals of Surgery. He is the Co-Director of the Opioid Prescribing Engagement Network or OPEN at the University of Michigan, which aims to apply a preventative approach to the opioid epidemic in the US through appropriate prescribing after surgery, dentistry and emergency medicine. Moreover, he is the Co-Director of the cross-campus Opioid Research Institute, which was launched in the spring of 2023. He leads multiple NIH grants studying these concepts and receives funding from the Michigan Department of Health and Human Services, SAMHSA, CDC, and multiple foundations. You can learn more about Dr. Brummett here, and you can follow Dr. Brummett @drchadb and the department of anesthesiology @UMichAnesthesia on X.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Cannabis and psychedelics: stigmatized substances or powerful therapeutics?
Today on The Fundamentals is Dr. Kevin Boehnke, research assistant professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. His current research focuses on therapeutic applications of cannabis and psychedelics. His goal is to rigorously assess appropriate use of these substances and to help address the public health harms caused by their criminalization.
Xray of a stem cell in a mouse brain.
Health Lab
Stem cells improve memory, reduce inflammation in Alzheimer’s mouse brains
Researchers improved memory and reduced neuroinflammation in a mouse model of Alzheimer’s Disease, suggesting another avenue for potential treatment.